Results 11 to 20 of about 1,227,180 (211)

Invasive Pulmonary Aspergillosis

Journal of Fungi, 2023
Invasive pulmonary aspergillosis is growing in incidence, as patients at risk are growing in diversity. Outside the classical context of neutropenia, new risk factors are emerging or newly identified, such as new anticancer drugs, viral pneumonias and ...
Marie-Pierre Ledoux, Raoul Herbrecht
doaj   +5 more sources

Mechanistic Basis of Super-Infection: Influenza-Associated Invasive Pulmonary Aspergillosis

Journal of Fungi, 2022
Influenza infection is a risk factor for invasive pulmonary aspergillosis in both immunocompetent and immunocompromised hosts. The purpose of this review is to highlight the epidemiology of influenza-associated invasive pulmonary aspergillosis and the ...
Keven Mara Robinson
doaj   +4 more sources

Subacute invasive pulmonary aspergillosis

Journal of Advanced Lung Health, 2021
Subacute invasive pulmonary aspergillosis (IPA) is an indolent cavitating infectious process which can mimic other chronic lung infections such as tuberculosis.
Ravindran Chetambath
doaj   +3 more sources

Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis [PDF]

Medical Mycology Case Reports, 2018
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in non-cirrhotic patients with diabetes mellitus, neutropenia, or treatment with corticosteroids.
Jon G. Persichino, Argun D. Can, Tam T. Van, Michele N. Matthews, Scott G. Filler   +4 more
doaj   +2 more sources

Rare concurrent invasive pulmonary aspergillosis in a critically Ill patient with hemorrhagic fever with renal syndrome: a case report [PDF]

BMC Infectious Diseases
Background Hantavirus infection frequently results in hemorrhagic fever with renal syndrome, which may be fatal in certain instances. invasive pulmonary aspergillosis is a rare concurrent symptom that requires considerable attention from clinicians. Case
Weiwei Yan, Alin Sun, Liming Wang, Jihong Zhang, Peng Chen   +4 more
doaj   +2 more sources

Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis [PDF]

Respiratory Medicine, 1995
Invasive pulmonary aspergillosis is a frequent complication in immunocompromised patients. The role of the prolonged use of steroids in predisposing to invasive aspergillosis has been recognized, but exceptionally described in asthmatic patients. We report the case of a 59-year-old woman with bronchial asthma treated with steroid therapy for a long ...
A. Ganassini, CAZZADORI, Angelo Antonio
openaire   +4 more sources

Invasive pulmonary aspergillosis [PDF]

Revista Clínica Española (English Edition), 2020
AbstractInvasive pulmonary aspergillosis (IPA) remains difficult to diagnose and to treat. Most common risk factors are prolonged neutropenia, hematopoietic stem cell or solid organ transplantation, inherited or acquired immunodeficiency, administration of steroids or other immunosuppressive agents including monoclonal antibodies and new small ...
L A, Fernández-Bermejo, G, Ramírez-Olivencia   +1 more
  +11 more sources

Pediatric Pulmonary and Thoracic Aspergillosis

Siriraj Medical Journal, 2020
Aspergillus infection can cause significant disease in an immunocompromised host and lungs are the most common site of infection. Various forms of aspergillus involving lung parenchyma have been described including aspergilloma, allergic bronchopulmonary
Preeyacha Pacharn, Punchama Pacharn, Chantima Rongviriyapanich, Thomas Bryce   +3 more
doaj   +1 more source

Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [PDF]

Current Medical Mycology, 2022
Background and Purpose: Influenza A and SARS-CoV-2 are risk factors for invasive pulmonary aspergillosis. Both influenza-associated pulmonary aspergillosis and COVID-19-associated pulmonary aspergillosis result in high mortality and poor clinical ...
Ahsan Syed, Kausar Jabeen, Joveria Farooqi, Hammad Niamatullah, Aisha Fareed Siddiqui, Safia Awan, Alishah Akbar, Irfan Muhammad   +7 more
doaj   +1 more source

Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™ [PDF]

, 2011
Background: Despite advances in the treatment, the morbidity and mortality rate associated with invasive aspergillosis remains unacceptably high (70–90%) in immunocompromised patients.
M N V Ravi Kumar, Sharp Andrew, Jagdishbhai L. Italia, Carter, Katharine C., Carter Katharine C., Kumar, M. N V Ravi, Kumar M. N. V. Ravi, Jagdishbhai L Italia, Italia Jagdishbhai L., Italia, Jagdishbhai L., Katharine C. Carter, M. N. V. Ravi Kumar, Andrew Sharp, Italia, Jagdishbhai L, Kumar, M N V Ravi, Warn, Peter, Warn Peter, Sharp, Andrew, Carter, Katharine C, Katharine C Carter, Peter Warn   +20 more
core   +5 more sources